Augustine Asset Management’s Novo Nordisk NVO Stock Holding History

Augustine Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.28M	Sell	33,798 -244	-0.7%	-$11.2K	0.28%	49
2026 Q2	$1.63M	Sell	34,042 -751	-2%	-$32.3K	0.33%	39
2026 Q1	$1.28M	Buy	34,793 +945	+3%	+$44.8K	0.29%	47
2025 Q4	$1.72M	Sell	33,848 -784	-2%	-$40.1K	0.34%	39
2025 Q3	$1.92M	Buy	34,632 +14,790	+75%	+$866K	0.39%	38
2025 Q2	$1.37M	Buy	19,842 +104	+0.5%	+$7.07K	0.37%	44
2025 Q1	$1.37M	Buy	19,738 +54	+0.3%	+$4.46K	0.4%	42
2024 Q4	$1.69M	Buy	+19,684	New	+$2.13M	0.45%	37
2016 Q4	–	Sell	-96,150	Closed	-$2M	–	68
2016 Q3	$2M	Sell	96,150 -270	-0.3%	-$6.69K	1.47%	24
2016 Q2	$2.59M	Buy	+96,420	New	+$2.64M	2.07%	18
2016 Q1	–	Sell	-137,376	Closed	-$3.99M	–	57
2015 Q4	$3.99M	Buy	137,376 +2,076	+2%	+$57.5K	3.08%	13
2015 Q3	$3.67M	Buy	135,300 +120	+0.1%	+$3.4K	2.8%	14
2015 Q2	$3.7M	Buy	135,180 +60	+0%	+$1.69K	2.76%	14
2015 Q1	$3.82M	Buy	+135,120	New	+$3.11M	2.69%	13

Other funds holding NVO

Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Cantor Fitzgerald Investment Advisors New York $1.47B AUM 20.15% 1-Year Est. Return

Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

VFM

Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return

ERP

Eldred Rock Partners San Antonio, Texas $451M AUM 38.39% 1-Year Est. Return

OFA

Oak Family Advisors Chicago, Illinois $385M AUM 12.33% 1-Year Est. Return

Augustine Asset Management's NVO Position: Q3 2026 in Review

Augustine Asset Management reduced its Novo Nordisk (NVO) stake by 0.72% in Q3 2026, selling an estimated $11.2K and leaving 33,798 shares worth $1.28M. The position accounts for 0.28% of the portfolio, ranked #49.

Augustine Asset Management first reported a position in NVO in Q1 2015 and has held it in 14 quarters since. The position peaked at $3.99M in Q4 2015. 208 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Augustine Asset Management held 33,798 shares of Novo Nordisk worth $1.28M as of Q3 2026.
Augustine Asset Management sold 244 Novo Nordisk shares in Q3 2026, an estimated $11.2K.
Novo Nordisk made up 0.28% of Augustine Asset Management's portfolio in Q3 2026, its #49 holding.
Augustine Asset Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 14 quarters since.
Augustine Asset Management's Novo Nordisk position peaked at $3.99M in Q4 2015.
208 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Augustine Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.